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Objective. To research the protective eﬀects and mechanisms of Radix Astragali injection on the intestinal mucosa of rats with
obstructive jaundice (OJ). Methods. The rats were randomly divided into sham-operated, model control and Radix Astragali
treated group. We observed the pathological changes of intestinal mucosa, expression levels of Bax and NF-κB proteins, and
apoptosis indexes in intestinal mucosa as well as serum NO, MDA and SOD contents, respectively, on 7d, 14d, 21d and 28d
after operation. Results. The pathological severity score (on 7d and 14d), apoptotic indexes (on 14d) of the intestinal mucosa and
serumMDAcontent(on14d)oftreatedgroupweresigniﬁcantlylowerthanthoseinthemodelcontrolgroup(P<. 05).Theserum
SOD contents (on all time points) of treated group were signiﬁcantly higher than those in the model control group (P<. 05). The
sham-operated group (on 21d) of the product of staining intensity and positive rate of Bax protein was signiﬁcantly lower than
model control group (P<. 05). Conclusion. Radix Astragali injection could protect the intestinal mucosa of OJ rats by increasing
the content of SOD, reducing the content of MDA, inhibiting the apoptosis and relieving the pathological changes of intestinal
mucosa.
1.Introduction
During obstructive jaundice, the impairment of intesti-
nal mucosal barrier and the translocation of endotoxins
and intestinal bacteria can cause intestinal infections and
secondary multiple organ injury, which are pivotal for
the deterioration of the disease [1–6]. Therefore, it is of
great signiﬁcance to protect the small intestinal mucosa
[7]. OJ is sensitive to auxiliary treatment with traditional
Chinese medicine. Astragalus injection, as an extract from
Radix Astragali, is characterized by low cost, extensive
pharmacological eﬀects and few side eﬀects and therefore
has unique advantages and prospects in the treatment of
OJ. Astragalus injection is one of the famous injections of
traditional Chinese medicine. Astragalus injection contains
polysaccharide, saponin, ﬂavones, and trace elements [8].
Although some studies [8, 9] showed that Astragalus could
signiﬁcantlyimprovetheoxygenfreeradical-scavengingabil-
ities, inhibit excessive inﬂammatory response, and thereby
mitigate hepatic and renal injury in OJ rats, no study on
the protective eﬀects of astragalus on intestinal mucosa was
found in domestic and foreign literature. In this study,
we investigated the protective eﬀects and mechanisms of
Astragalus injection on small intestinal mucosa of OJ rats
to provide a theoretical basis for clinical application of this
injection.
2.MaterialsandMethods
2.1. Materials. The healthy male SD rats of clean grade,
weighing between 270 and 330g, were provided by the
Laboratory Animal Research Center of the Zhejiang Uni-
versity of Traditional Chinese Medicine (Hangzhou, China).
T h es o d i u mp e n t o b a r b i t a lw a sp u r c h a s e df r o mS i g m a
Corporation (Sigma-Aldrich, St. Louis, MO, USA). Radix
Astragali injection (each 10mL vial contains active com-
ponents equivalent to 20g of the original medicine) was2 Mediators of Inﬂammation
purchased from Chiatai Qingchunbao Pharmaceutical Co.,
Ltd (Hangzhou, China). The serum nitrogen monoxidum
(NO), malonaldehyde (MDA), and superoxide dismutase
(SOD) kits were all purchased from Nanjing Jiancheng
Bioengineering Research Institute (Nanjing, China), and
the calculation units for content are respectively μmol/L,
nmol/mL, and U/mL. The anti-NF-κB P65 and anti-Bax
antibody were purchased from Santa Cruz Biotechnology,
Inc. (Santa Cruz, California, USA) TUNEL assay kit was
purchased from Takara Bio Inc. (Jingdu, Japan).
2.2. Methods
2.2.1. Animal Grouping and Preparation of OJ Models.
180 rats were utilized for OJ-associated experiments and
randomly divided into sham-operated, model control, and
treated group (n = 60), which were further randomly
subdivided into 7d, 14d, 21d, and 28d groups (n =
15) according to time duration after operation. After rats
were anesthetized with an intraperitoneal injection of 2.5%
sodium pentobarbital (0.2mL/100g), the abdominal cavity
was opened to identify and dissociate common bile duct
along the hepatoduodenal ligament. For rats in the model
control group and the treated group, the proximal end of
common bile duct was double ligated with surgical threads,
common bile duct was cut oﬀ,a n dal a y e r e ds u t u r eo f
the abdominal wall was performed to close the abdominal
cavity. For rats in the sham-operated groups, common bile
duct was only dissociated but not ligated, and a layered
suture of the abdominal wall was also performed to close
the abdominal cavity. An intraperitoneal injection of Radix
Astragali injection at a dose of 0.75mL/100g/d was given to
ratsinthetreatedgroupswhileequalvolumeofphysiological
saline solution wasused in thesham-operated and themodel
control group. Diﬀerent injection was maintained until the
end of the 7-day, 14-day, 21-day, and 28-day observation
period in the corresponding groups [8].
2.2.2. Determination of Experimental Parameters. The mor-
tality rate of rats in each group was recorded. After mercy
killing rats anesthetized by sodium pentobarbital in batches,
we collected the serum of rats to detect NO, MDA and SOD
contents and observed the pathological changes of intestinal
muscoa. The determination of these serum parameters was
conducted according to the instructions provided by the
kits. The pathological severity score of intestinal muscoa was
conducted according to our report for related standard. And
then we prepared the tissue microarrys section for intestine
tissue with diameter of 1.5mm, stained them, observed the
changes in the expression levels of Bax and NF-κBP 6 5
proteins as well as the apoptosis index of intestinal muscoa.
2.2.3. Immunohistochemical Staining of Bax and NF-κBP 6 5
Proteins in the Intestinal Muscoa. Envision two-step method
wasusedtodetecttheexpressionlevelsofBaxandNF-κBP65
protein in the intestinal muscoa. The evaluation standard
was as follows: (1) the staining intensity was evaluated
according to the extent of cell coloration: “−”r e p r e s e n t e d
negative staining; “+” represented mild staining, positively
stained cells showed a yellow pigment; “++” represented
moderate staining, positively stained cells showed a brown
pigment; “+++” represented intense staining, positively
stained cells showed a dark brown pigment, each of which
was scored as 0, 1, 2, and 3 points, respectively, during
statisticalanalysis;(2).theevaluationstandardofthepositive
rate:therewasnopositivecells(−);thepercentageofpositive
cells was less than 25% (+); the percentage of positive
cells ranged between 26% and 50% (++);the percentage of
positive cells was more than 50% (+++), each of which was
scored as 0, 1, 2, and 3 points, respectively, during statistical
analysis.
2.2.4. TUNEL Staining in the Intestinal Muscoa. In tis-
sue microarrays sections, DNA nick in situ end-labeling
(TUNEL) staining steps were performed as follows: baking
sections under 60◦C for 30 minutes, routine deparaﬃnage,
and Milli-Q wash for 5 minutes. Processing tissue with
Protease K (10ug/uL) under room temperature for 15
minutes, PBS washes for 5 minutes. Using 3% H2O2 solution
to block endogenous peroxydase for 5 minutes, PBS wash for
5m i n u t e s ×twice. Adding 30 uL reaction solution in freezing
condition (TdT Enzyme: Labeling Safe Buﬀer = 1 : 10), 37◦C
incubation for 90 minutes, PBS wash for 5 minutes × twice.
Adding 50ul Anti-FITC HRP Conjugate, 37◦C incubation
for 30 minutes, PBS wash for 5 minutes × twice. DAB
coloration, Milli-Q wash to terminate coloration. Hema-
toxylin counterstain, water wash and wash fully with water
after diﬀerentiation till return blue; routine dehydration and
transparence; neutral gum mounting. The apoptotic index
was calculated. Apoptotic index = apoptotic cell count/total
cell count ×100%.
2.2.5. Statistical Analysis. After input into the Excel sheets,
the compiled data was read into SPSS15.0 for further
analysis. Normal data was expressed as means (standard
deviation) while nonnormal data were expressed as medians
(interquartile range). Analysis of variance and pairwise
comparisons were used in normal data; whereas nonnormal
data were subjected to nonparametric test, among which
Kruskal-Wallis H test was used for pairwise comparisons
and Mann-Whitney U test for multiple comparisons. Yates’
chi-square test (χ2) was used for intergroup comparisons of
mortality rates.
3. Results
3.1. Comparison of Mortality Rate. All rats were alive in the
sham-operated groups on all time points after operation. 2
and 1 rats died in the model control and treated group on
7d, respectively; 4 and 3 rats died in the model control and
treated group on 14d, respectively; 4 rats died in both model
control and treated group on 21d; 7 and 6 rats died in the
model control and treated group on 28d, respectively. The
total mortality rate of the model control and treated groupMediators of Inﬂammation 3
Figure 1: Sham-operated group-28d mucous membrane of small
intestine is approximately normal HE ×100.
on 28d were signiﬁcantly higher than those in the sham-
operated group (P<. 001). There was no marked diﬀerence
between the model control and treated group (P>. 05).
3.2. Pathological Changes in Intestinal Mucosa
3.2.1. Sham-Operated Group
Gross Pathological Changes. No obvious abnormality was
seen.
Pathological Changes under Light Microscopy. No obvious
diﬀerence in pathological changes was observed among each
timepointafteroperation.Theintestinalmucosawasnormal
inthemajorityofrats.Theintestinalmucosalepitheliumwas
not intact and inﬂammatory cell inﬁltration of proper layer
was seen in very few rats (see Figure 1).
3.2.2. Model Control Group
Gross Pathological Changes. On 7d after operation, intestinal
wallandperitoneumbecamejaundiceinthemajorityofrats.
On 14d after operation, varying degrees of yellow staining of
the intestinal wall and peritoneum were seen in the majority
of rats. The intestinal canal was enlarged and showed ﬂuid
retention. On 21 and 28d after operation, yellow staining of
the intestinal wall and peritoneum were seen in all rats.
Pathological Changes under Light Microscopy. No obvious
diﬀerence in pathological changes was observed among each
time point after operation. On 7d after operation, intestinal
mucosa was normal in the majority of rats, and the edema of
submucous layer were present in very few rats. On 14d after
operation, intestinal mucosa was normal in the majority of
rats but not intact in some rats, and the edema of proper
layer, submucous layer, and serosal layer were seen in some
rats.On21dafteroperation,intestinalmucosawasnotintact
in the majority of rats, the edema of proper layer, submucous
layer, and serosal layer were seen in the majority of rats,
and very few rats showed no abnormality of the intestinal
Figure 2: Model control group-28d a large inﬂammatory cells
inﬁltration in small intestinal wall HE ×200.
Figure3:Modelcontrolgroup-28dasmallquantityacidophilecells
inﬁltration in intestinal lamina propria HE ×200.
mucosa. On 28d after operation, focal necrosis in intestinal
mucosal epithelium as well as the edema of proper layer,
submucous layer and serosal layer were seen in the majority
of rats (see Figures 2 and 3).
3.2.3. Treated Group
Gross Pathological Changes. On 7d after operation, no obvi-
ousdiﬀerencewasobservedwhencomparedtothatinmodel
controlgroup.On14dafteroperation,intestinalwallbecame
jaundice in half of the rats, but intestinal canal was not
e n l a r g e da n ds h o w e dn oﬂ u i dr e t e n t i o n .O n2 1 ,a n d2 8 d
after operation, no obvious diﬀerence was observed when
compared to those in model control group.
Pathological Changes under Light Microscopy. The patho-
logical changes in the small intestine of rats at various
time points showed varying degrees of mitigation. On day
7 in treated group, the small intestine of the majority of
rats showed no abnormality while the small intestine of
extremely few rats showed inﬂammatory cell inﬁltration in
proper layer, submucous layer, and serosal layer. On day 144 Mediators of Inﬂammation
Table 1: Comparison of diﬀerent pathological indexes (M(QR)).
Index Time Sham-operated group Model control group Treated group
Pathological severity score
7d 0.0 (1.0) 1.0 (1.0)∗ 0.0 (1.0)∗+
14d 0.0 (1.0) 1.0 (2.0)∗ 1.0 (1.0)+
21d 0.0 (0.0) 2.0 (1.0)∗ 0.0 (1.0)
28d 0.0 (0.0) 2.0 (1.0)∗ 1.0 (0.0)
Product of the staining intensity and positive rate of Bax
7d 0.0 (0.0) 0.0 (1.0) 0.0 (1.0)
14d 0.0 (1.0) 2.0 (4.0) 0.0 (1.5)
21d 0.0 (0.0)+ 1.0 (2.0) 0.0 (1.0)
28d 0.0 (1.0) 0.5 (1.5) 1.0 (2.0)
Apoptosis index
7d 0.0 (0.0)+ 0.0 (0.0) 0.0 (0.0)
14d 0.0 (0.0) 0.0 (0.01) 0.0 (0.0)+
21d 0.0 (0.0)+ 0.0 (0.01) 0.0 (0.0)
28d 0.0 (0.0)+ 0.0 (0.0) 0.0 (0.0)
Product of the staining intensity and positive rate of NF-κB
7d 0.0 (0.0) 0.0 (2.0) 0.0 (2.0)
14d 0.0 (2.0) 0.0 (4.0) 0.0 (1.0)
21d 0.0 (0.0) 0.0 (4.0) 0.0 (3.0)
28d 0.0 (2.0) 1.0 (3.0) 0.0 (1.0)
Note: Compare to sham-operated group, ∗P <. 05 and ∗∗P <. 01; Compare to model control group, +P <. 05 and ++P <. 01.
in treated group, the small intestine of some rats showed
no abnormality, the small intestine of some rats showed
inﬂammatory cell inﬁltration in proper layer, submucous
layer, and serosal layer, and the small intestine of extremely
few rats showed focal necrosis in the mucosa. On day 21
in treated group, the small intestine of some rats showed
no abnormality while the other rats showed inﬂammatory
cell inﬁltration in proper layer, submucous layer and serosal
layer. On day 28 in treated group, the small intestine of some
rats showed inﬂammatory cell inﬁltration in proper layer,
submucous layer and serosal layer while the extremely few
rats showed no abnormality (see Figure 4).
3.3. Comparison of the Pathological Severity Scores. The
pathological score standard of intestinal mucosa was referred
the report [10]. Pathological severity scores of the sham-
operated group (on 7, 14, and 21d) was signiﬁcantly lower
than model control group (P<. 05). The sham-operated
group (on 7d) were signiﬁcantly lower than treated group
(P<. 05). The scores in treated group (on 7 and 14d)
were signiﬁcantly lower than those in model control group
(P<. 05) see Table 1.
3.4. Comparison of the Product of Staining Intensity and
Positive Rate of NF-κB Protein. The positive signals for
NF-κB protein were mainly localized in the cytoplasm of
intestinal mucosa epithelial cells and occasionally in the
cytoplasm of inﬂammatory cells. The positive signals were
mainly localized in the cytoplasm though few were seen in
the nucleus. On all time points after operation, no marked
diﬀerence was noted among all groups (P>. 05); see Table 1,
Figures 5 and 6.
3.5. Comparison of the Product of Staining Intensity and
Positive Rate of Bax Protein. The sham-operated group (on
21d) was signiﬁcantly lower than model control group (P<
.05); see Table 1, Figures 7, 8, 9,a n d10.
3.6. Comparison of the Apoptosis Index. The sham-operated
group (on 7, 21 and 28d) was signiﬁcantly lower than model
control group (P<. 05). The treated group (on 14d) was
signiﬁcantly lower than model control group (P<. 05); see
Table 1, Figure 11.
3.7. Comparison of Serum MDA. The sham-operated group
(on all time points) was signiﬁcantly lower than model
control and treated group (P<. 01). The treated group
(on 14d) was signiﬁcantly lower than model control group
(P<. 05); see Table 2.
3.8. Comparison of Serum SOD. The sham-operated group
(on all time points) was signiﬁcantly higher than model
control and treated group (P<. 05). The treated group (on
all time points) was signiﬁcantly higher than model control
group (P<. 05); see Table 2.
3.9. Comparison of Serum NO. The sham-operated group
(on 7 and 14d) was signiﬁcantly lower than model control
and treated group (P<. 01); see Table 2.
4. Discussion
The intestine is the largest lymphoid organ of the body.
Since the intestinal canal has a constant contact with viruses,
bacteria and foreign matters, the surface mucosa of the intes-
tine plays an important role in preventing the invasion of
harmful substances. Therefore, protection of small intestinal
mucosa is a key to the treatment of OJ. During OJ, high-
concentration bile salts and hyperbilirubinemia may be twoMediators of Inﬂammation 5
Table 2: Comparison of diﬀerent indexes in blood (X ±S).
Index Time Sham-operated group Model control group Treated group
MDA
7d 2.5 ±1.2 21.6 ± 3.2∗∗ 22.8 ± 4.8∗∗
14d 2.3 ±1.4 23.4 ± 3.4∗∗ 19.6 ± 7.2∗∗++
21d 3.1 ±1.7 27.1 ± 4.7∗∗ 21.0 ± 6.2∗∗
28d 3.6 ±1.0 34.0 ± 9.2∗∗ 27.0 ± 12.3∗∗
SOD
7d 56.87 ±12.62 31.27 ± 12.77∗ 43.61 ± 8.77∗+
14d 53.68 ±9.14 32.16 ± 8.39∗ 45.28 ± 11.18∗+
21d 57.93 ±12.77 34.25 ± 12.08∗ 46.38 ± 16.81∗+
28d 57.90 ±7.83 34.95 ± 9.76∗ 46.88 ± 11.69∗+
NO
7d 24.0 ±11.0 36.0 ± 27.0∗∗ 30.0 ± 17.0∗∗
14d 25.0 ±10.0 47.0 ± 32.0∗∗ 37.0 ± 17.0∗∗
21d 26.0 ±13.0 48.0 ± 14.0 44.0 ± 16.0
28d 29.0 ±8.0 69.0 ± 28.0 50.0 ± 15.0
Note: Compare to sham-operated group, ∗∗P <. 05 and ∗P <. 01; Compare to model control group, +P <. 05 and ++P <. 01.
Figure 4: Treated group-28d mucous membrane of small intestine
is approximately normal HE ×200.
major factors contributing to the production of oxygen free
radicals. Thus, inhibition of hyperbilirubinemia can reduce
OJ-induced injury [11, 12]. To a certain extent, MDA is a
reliable parameter that can reﬂect, to a certain extent, oxygen
freeradical-inducedlipidperoxidationandtheextentoflipid
peroxidation-induced damage to the body. SOD is able to
speciﬁcally scavenge superoxide anion radicals and thereby
exerts some protective eﬀects on the body. This study indi-
cated that the content of serum MDA in astragalus treated
group was signiﬁcantly lower than that in model control
group, the content of SOD in astragalus treated group was
signiﬁcantly higher than that in model control group, and
the pathological injury of small intestinal mucosa showed
varying degrees of mitigation, suggesting that astragalus can
reduce the content of serum MDA, increase the content of
SOD and mitigate lipid peroxidation-induced cytoplasmic
membrane damage, thereby exert protective eﬀects on the
small intestinal mucosa. Moderate NO levels are able to
expand blood vessels and improve microcirculation, while
high levels of NO can aggravate OJ-induced haemodynamic
Figure 5: Model control group-28d mucous membrane of small
intestine (+++) NF-κB ×200.
disturbance in the liver and kidney. Han et al. [13]p r o v e d
thatiNOShadanelevatedlevelintheliverofOJratsandthus
could induce the production of a large amount of NO and
causeendothelialcelldysfunction.Ourresultsindicatedthat,
though the level of serum NO in astragalus treated group
was lower than that in model control group, no statistical
diﬀerence was observed. We speculate that it may be due to
too small sample size.
Nuclear factor κB( N F - κB) is a multieﬀect transcrip-
tion regulatory factor that controls the transcription of
a variety of inﬂammation-, immunity-, and hyperplasia-
r e l a t e df a c t o r s ,s u c ha sT N F - α,I L - 1 β,i N O S ,a n dI C A M - 1 .
Upon activation, NF-κB is able to induce a cascade reaction
of cytokines [14] and impair the structure and function
of multiple organs [15–18]. Some experimental studies
showed that NF-κB may induce or aggravate small intestinal
ischemia/reperfusion injury [19], promote intestinal epithe-
lialcellapoptosis [20],andtherebyinduceintestinal damage.
This study showed that at all time points after operation,
the expression levels of NF-κB protein showed no signiﬁcant6 Mediators of Inﬂammation
Figure 6: Model control group-28d mucous membrane of small
intestine (++) NF-κB ×200.
Figure 7: sham-operated group-21d mucous membrane of small
intestine (−)B a x×200.
Figure 8: Model control group-21d mucous membrane of small
intestine (+++) Bax ×200.
Figure 9: Model control group-21d mucous membrane of small
intestine (++) Bax ×200.
Figure 10:Treatedgroup-21dmucousmembraneofsmallintestine
(+) Bax ×200.
Figure 11: Treated group-21d a few apoptotic cells in mucous
membrane of small intestine TUNEL ×200.Mediators of Inﬂammation 7
diﬀerence among each group (P>. 05). So we surmise that
NF-κB protein has no signiﬁcant impact on the pathological
injury of the small intestine mucosa of OJ rats.
Apoptosis is a kind of gene-controlled physiological cell
death to maintain the body’s normal physiological functions
and stability. The stability of small intestinal mucosa also
depends on the equilibrium between the proliferation and
apoptosis of epithelial cells [21]. Some factors such as
ischemia/reperfusion injury, bacterial infections and nutri-
tional deﬁciencies may induce the apoptosis of intestinal
epithelial cells [22–27] and cause intestinal dysfunction [28,
29]. Yang et al. [30] found that the total extract of astragalus
had inhibitory eﬀects on both in vivo and in vitro hepatic
cell injury and apoptosis. In the present study, we found that,
on day 14, the apoptosis index in small intestinal mucosa
in astragalus treated group was signiﬁcantly lower than
that in model control group, and small intestinal mucosal
inﬂammation and necrosis and microvilli defects in treated
group were milder than those in model control group,
indicating that astragalus can exert protective eﬀects on the
small intestinal mucosa of OJ rats through inhibiting the
apoptosis of small intestinal mucosal epithelial cells. Bax, as
anapoptosis-inducing gene[31–35],canpromoteBcl-2[36–
38] or Bcl-x dimer formation and thus induce cell apoptosis.
In this study, no statistical diﬀerence existed in the products
of the staining intensity and the positive staining rate of Bax
protein at all time points was noted between treated group
and model control group, suggesting that Bax protein may
have no impact on OJ-induced intestinal mucosa injury and
other unknown factors are involved in this process.
Insummary,astragalusinjectioncanincreasethecontent
of serum SOD, decrease the content of MDA, and inhibit the
apoptosis of small intestinal mucosa cells, thereby mitigate
the pathological injury of the small intestinal mucosa and
exerting protective eﬀects on the small intestinal mucosa of
OJ rats. However, it is worth mentioning that the therapeutic
eﬀects of astragalus are limited and auxiliary. Therefore,
combined use of other drugs that can protect the small
intestinal mucosa is needed during the course of treatment.
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